Pathogenesis and treatment of anemia in inflammatory bowel disease
- 1 February 2010
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (2) , 175-178
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor- treatmentHaematologica, 2009
- Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cellsFEBS Letters, 2004
- Iron, anaemia, and inflammatory bowel diseasesGut, 2004
- Cytokine-mediated regulation of iron transport in human monocytic cellsBlood, 2003
- Recent developments in the anemia of chronic disease.2003
- Prediction of response to iron sucrose in inflammatory bowel disease-associated anemiaAmerican Journal of Gastroenterology, 2001
- Nutritional deficiencies and blunted erythropoietin response as causes of the Amemia of critical illnessJournal of Critical Care, 2001
- Serum transferrin receptor in children and adolescents with inflammatory bowel diseaseEuropean Journal of Pediatrics, 2000
- Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritisBlood, 1996
- Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: Results in three patientsGastroenterology, 1993